Pediatrician-Parent Conversations About Human Papillomavirus Vaccination: An Analysis of Audio Recordings

Sturm, Lynne; Donahue, Kelly L.; Kasting, Monica L.; Kulkarni, Amit; Brewer, Noel T.; Zimet, Gregory D.

doi:10.1016/j.jadohealth.2017.02.006

Cited by 72 publications

(58 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While baseline knowledge about HPV epidemiology, vaccination coverage, and vaccine administration and safety information is important, information on specific opportunities for quality improvement is arguably even more important, given that provider behavior is a key reason for low uptake [22]. For example, research suggests that CME can assist providers in improving their HPV vaccine communication by using announcements to introduce vaccination, emphasizing cancer prevention, and consistently recommending same-day vaccination for male and female patients by age 12 [23–25]. Our findings indicate that these provider communication strategies and other components of successful HPV vaccine delivery may be underrepresented in the current CME offerings.…”

Section: Discussionmentioning

confidence: 99%

Content of web-based continuing medical education about HPV vaccination

Kornides

Garrell

Gilkey

2017

Vaccine

View full text Add to dashboard Cite

Background Addressing low HPV vaccination coverage will require U.S. health care providers to improve their recommendation practices and vaccine delivery systems. Because readily available continuing medical education (CME) could be an important tool for supporting providers in this process, we sought to assess the content of web-based CME activities related to HPV vaccination. Methods We conducted a content analysis of web-based CME activities about HPV vaccination available to U.S. primary care providers in May-September 2016. Using search engines, educational clearinghouses, and our professional networks, we identified 15 activities eligible for study inclusion. Through a process of open coding, we identified 45 commonly occurring messages in the CME activities, which we organized into five topic areas: delivering recommendations for HPV vaccination, addressing common parent concerns, implementing office-based strategies to increase HPV vaccination coverage, HPV epidemiology, and guidelines for HPV vaccine administration and safety. Using a standardized abstraction form, two coders then independently assessed which of the 45 messages each CME activity included. Results CME activities varied in the amount of content they delivered, with inclusion of the 45 messages ranging from 17% to 86%. Across activities, the most commonly included messages were related to guidelines for HPV vaccine administration and safety. For example, all activities (100%) specified that routine administration is recommended for ages 11 and 12. Most activities (73%) also noted that provider recommendations are highly influential. Fewer activities modeled examples of effective recommendations (47%), gave specific approaches to addressing common parent concerns (47%), or included guidance on office-based strategies to increase coverage (40%). Conclusions Given that many existing CME activities lack substantive content on how to change provider practice, future activities should focus on the practical application of interpersonal and organizational approaches for improving HPV vaccine delivery in the clinical setting.

show abstract

Section: Discussionmentioning

confidence: 99%

Content of web-based continuing medical education about HPV vaccination

Kornides

Garrell

Gilkey

2017

Vaccine

View full text Add to dashboard Cite

show abstract

“…[3][4][5] Studies find that providers use different communication strategies to recommend the HPV vaccine and that some styles may be more effective at increasing vaccine receipt. [6][7][8][9][10][11] However, most studies rely on providers' and parents' reports of vaccine recommendation rather than on actual conversations, and the validity of recall-based data may be limited by social desirability and recall biases. In the only known analysis of audio-recorded HPV discussions, Sturm et al (2017) noted that many pediatricians recommended delay or provided parents with mixed messages about vaccination.…”

Section: Introductionmentioning

confidence: 99%

“…[6][7][8][9][10][11] However, most studies rely on providers' and parents' reports of vaccine recommendation rather than on actual conversations, and the validity of recall-based data may be limited by social desirability and recall biases. In the only known analysis of audio-recorded HPV discussions, Sturm et al (2017) noted that many pediatricians recommended delay or provided parents with mixed messages about vaccination. 9 Because scant research has explored actual conversations between providers and parents, the effect of parental pre-visit vaccine intention on vaccination, or the effect of conversation style on parental satisfaction, we collected data on parental previsit vaccine intentions, providers' recommendation styles, vaccine uptake, and parent satisfaction, using parent surveys and audio-recordings of parent-provider-child vaccine discussions during medical visits at samples of diverse participating sites.…”

Section: Introductionmentioning

confidence: 99%

Indicated or elective? The association of providers' words with HPV vaccine receipt

Fenton

Eun

Clark

et al. 2018

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

“…Social views and myths about sexual behavior in conservative societies may mask the true health risks associated with the virus. Another important barrier is the pediatricians’ perception of parental resistance or hesitancy concerning HPV vaccination . From the viewpoint of the healthcare providers, delaying the vaccination by categorizing it as an optional vaccine, failure to endorse the vaccine strongly and lack of convincing language were perceived to be the significant reasons culminating in parental nonacceptance .…”

Section: Discussionmentioning

confidence: 99%

“…Another important barrier is the pediatricians’ perception of parental resistance or hesitancy concerning HPV vaccination . From the viewpoint of the healthcare providers, delaying the vaccination by categorizing it as an optional vaccine, failure to endorse the vaccine strongly and lack of convincing language were perceived to be the significant reasons culminating in parental nonacceptance . Parental education regarding the risk of HPV‐associated nongenital cancers, the possibility of various nonsexual modes of transmission and vaccinating preadolescent boys also will alleviate the stigma associated with the vaccine .…”

Section: Discussionmentioning

confidence: 99%

Global human papilloma virus vaccine implementation: An update

Sabeena

Bhat

Kamath

et al. 2018

J of Obstet and Gynaecol

View full text Add to dashboard Cite

Human papillomavirus (HPV) infections continue to be one of the most common sexually transmitted infections worldwide. The oncogenic potential of this virus was well established in anogenital malignancies and oropharyngeal cancers. Even though a fall in cervical cancer rates has been reported worldwide, the subsequent rise in HPV-associated head and neck cancers among men and women have been reported from developed countries, necessitating the vaccination of adolescent boys as well. The objective of this narrative review is to provide an update on the current status of HPV vaccination worldwide. This will be helpful for clinicians in counseling parents and guardians as this vaccine mainly targets sexually naïve preadolescents. An electronic search of the databases was carried out to retrieve information concerning HPV vaccine implementation between July 2006 and 2017, with special emphasis on the current viewpoints, controversies and ethical issues. Globally, 74 countries have implemented the HPV vaccine in the national immunization schedule, and this vaccine is listed as an essential medicine by WHO. About 60% of the low- and lower-middle-income countries have implemented the vaccine with financial assistance from Gavi and WHO. The HPV vaccine is a safe vaccine with no serious adverse effects as per the data available from developed nations as well as low/lower middle/upper middle-income countries. However, long-term follow-up is essential to substantiate the impact of the vaccination programs in cancer prevention.

show abstract

Pediatrician-Parent Conversations About Human Papillomavirus Vaccination: An Analysis of Audio Recordings

Abstract: Our findings highlight the need to develop and evaluate physician-focused trainings on using presumptive language for same-day HPV vaccination.

Cited by 72 publications

References 18 publications

Content of web-based continuing medical education about HPV vaccination

Content of web-based continuing medical education about HPV vaccination

Indicated or elective? The association of providers' words with HPV vaccine receipt

Global human papilloma virus vaccine implementation: An update

Contact Info

Product

Resources

About